Search Results - "Scullin, Paula"

New Advances in the Second‐Line Treatment of Small Cell Lung Cancer by Hurwitz, Jane L., McCoy, Francis, Scullin, Paula, Fennell, Dean A.

“…Lung cancer is the leading cause of cancer‐related death in the U.K., with small cell histology accounting for 15%–20% of cases. Small cell lung cancer (SCLC)…”
Get full text

Patient experience of consent for systemic anti-cancer therapies (SACT): perspectives of patients with lung cancer versus other cancers by Ryan, Megan, Johnston, David, Delaney, Nicola, Campbell, Lynn, Scullin, Paula

Get full text

101 - Patient experience of consent for systemic anti-cancer therapies (SACT): perspectives of patients with lung cancer versus other cancers by Ryan, Megan, Johnston, David, Delaney, Nicola, Campbell, Lynn, Scullin, Paula

Get full text

54 A population-based review of early-onset lung cancer patients in Northern Ireland by Russell, Ashleigh, Valand, Dharmesh, McGarry, Laura, Ryan, Megan, Connon, Roisin, Scullin, Paula, Campbell, Lynn

Get full text

Review of the work-up for patients diagnosed with malignant pleural mesothelioma in Northern Ireland 2019–2020 by Burke, David, Aziz, Nasreen, Scullin, Paula, Campbell, Lynn

Get full text

The integration of occupational therapy at the point of diagnosis in lung cancer by Evans, Nicola, Cheshire, Donna, Campbell, Lynn, Scullin, Paula

Get full text

68 - Reflex PDL-1 testing for all NSCLC stages and clinical outcomes: the Northern Irish Experience 2017–2021 by Johnston, David, Tee, Jin, Abladey, Anthony, Lyttle, Anne, Hanna, Gerard, McAleese, Jonathan, James, Jacqueline, Quinn, Christine, Scullin, Paula, Campbell, Lynn, Walls, Gerard

Get full text

Reflex PDL-1 testing for all NSCLC stages and clinical outcomes: the Northern Irish Experience 2017–2021 by Johnston, David, Tee, Jin, Abladey, Anthony, Lyttle, Anne, Hanna, Gerard, McAleese, Jonathan, James, Jacqueline, Quinn, Christine, Scullin, Paula, Campbell, Lynn, Walls, Gerard

Get full text

Reviewing deaths within 30 days of systemic anti-cancer therapy: Driving quality in a regional chemotherapy service by Forde, Caroline, Scullin, Paula, Edgar, Lynne, McAleer, James J, Coyle, Victoria M

“…Abstract only 112 Background: Systemic anti-cancer therapy (SACT) administration rate at the end of life has been deemed a key metric for assessing quality of…”
Get full text

Re-challenge chemotherapy with gemcitabine plus carboplatin in patients with non-small cell lung cancer by Khan, Khurum, Hanna, Gerard G, Campbell, Lynn, Scullin, Paula, Hussain, Adnan, Eakin, Ruth L, McAleese, Jonathan

“…Despite recent improvements to current therapies and the emergence ot novel agents to manage advanced non-small cell lung cancer （NSCLC）, the patients＇ overall…”
Get full text

Identifying patients with diabetes in a day‐case systemic anti‐cancer therapy population: the Belfast Regional Oncology Centre experience by Waterworth, Adam, Hamilton, Ashleigh, Johnston, Philip, Todd, Anna, Connolly, Grainne, Nugent, Ailish, Scullin, Paula, McKenna, Sarah, Lawless, Sarah, Wallace, Helen, Wallace, Ian

“…Patients undergoing systemic anti‐cancer treatment (SACT) often receive short courses of high dose steroids which may cause hyperglycaemia and potentially…”
Get full text

Chasing the Golden Hour – Lessons learned from improving initial neutropenic sepsis management by Forde, Caroline, Scullin, Paula

“…Neutropenic sepsis remains a time critical and potentially fatal complication of systemic anti-cancer therapy. A target ‘door to needle’ time of one hour for…”
Get full text

Interleukin-8 signaling promotes androgen-independent proliferation of prostate cancer cells via induction of androgen receptor expression and activation by Seaton, Angela, Scullin, Paula, Maxwell, Pamela J., Wilson, Catherine, Pettigrew, Johanna, Gallagher, Rebecca, O'Sullivan, Joe M., Johnston, Patrick G., Waugh, David J. J.

“…The aim of our study was to assess the importance of the CXC chemokine and interleukin (IL)-8 in promoting the transition of prostate cancer (CaP) to the…”
Get full text

Improving the safety of chemotherapy prescribing in oncology through the introduction of an assessment proforma by Scullin, Paula, Devlin, Olivia, Forde, Caroline

“…Chemotherapy remains a high risk treatment with the potential to cause significant patient morbidity and mortality. In the UK the Manual for Cancer Services:…”
Get full text

Response to chemotherapy is predictive in relation to longer overall survival in an individual patient combined-analysis with pleural mesothelioma by Blayney, Jaine K, Ceresoli, Giovanni L, Castagneto, Bruno, O’Brien, Mary E.R, Hasan, Baktiar, Sylvester, Richard, Rudd, Robin, Steele, Jeremy, Busacca, Sara, Porta, Camillo, Mutti, Luciano, O’Byrne, Kenneth J, Scullin, Paula, Gaafar, Rabab, Baas, Paul, Van Meerbeeck, Jan, Fennell, Dean A

“…Abstract Background There is currently no early predictive marker of survival for patients receiving chemotherapy for malignant pleural mesothelioma (MPM)…”
Get full text

A sudden headache by Kinney, Michael, Ang, Melvyn, Scullin, Paula

Get full text

Afatinib treatment in advanced non-small cell lung cancer by Hurwitz, Jane L, Scullin, Paula, Campbell, Lynn

“…Despite some recent advances in the management of advanced non-small cell lung cancer (NSCLC), prognosis for these patients remains poor. Small molecule…”
Get full text

Myoclonic jerks associated with gabapentin by Scullin, Paula, Sheahan, Patricia, Kelly, Sheila

“…Neuropathic pain is often difficult to treat and may be refractory to routine analgesic measures, including opioid therapy. Gabapentin has been used in the…”
Get full text